McDonnell
Boehnen Hulbert & Berghoff LLP will be offering a live webinar on "Biotechnology Patents at the U.S. Supreme
Court: 2012-2013 Term" on July 11, 2013 from 10:00 am to 11:15 am
(CT).  Patent Docs co-author and MBHB attorney Dr. Kevin Noonan will
discuss the outcome of three cases that have been or will be decided by the
U.S. Supreme Court this year:

•
Bowman v. Monsanto, a case involving the application of the
patent exhaustion doctrine to recombinant soybeans

•
FTC v. Watson, involving the FTC's allegations that
"reverse payment" settlement agreements between branded and generic
drug companies in ANDA litigation are anticompetitive and violate antitrust law

•
Association for Molecular Pathology v. Myriad Genetics, Inc., addressing
the question "Are human genes patentable?"

Dr.
Noonan will discuss these cases and their effects on the biotechnology
industry, particularly in view of recent trends at the Supreme Court regarding
the scope of patenting, as well as discuss the Supreme Court's decision in Mayo
Collaborative Services v. Prometheus Laboratories, Inc. from last
term, which reintroduced patent law concepts that have been dormant for half a
century.

While
there is no fee to participate, attendees must register in advance.  Those wishing to register can do so here.  CLE credit is pending for the states of California,
Georgia, Illinois, North Carolina, New Jersey, New York and Virginia.